Related Experiment Videos
Genetic control of diabetes progression
A Gonzalez1, J D Katz, M G Mattei
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/INSERM, Strasbourg, France.
Immunity
|January 16, 1998
Summary
Researchers studied autoimmune diabetes genetics using a T cell receptor transgenic mouse model. They identified five genomic intervals influencing disease progression, simplifying the analysis of diabetes susceptibility loci.
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Autoimmune diabetes in humans and nonobese diabetic mice involves complex genetics with numerous susceptibility loci.
- Understanding the genetic basis of autoimmune diabetes is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the genetic factors influencing autoimmune diabetes using a simplified T cell receptor transgenic mouse model.
- To identify specific genomic intervals that control the kinetics and penetrance of diabetes.
Main Methods:
- Utilized the BDC2.5 T cell receptor transgenic mouse model on two different genetic backgrounds.
- Analyzed the initiation, kinetics, and penetrance of insulitis and diabetes.
- Correlated disease differences with variations in specific genomic intervals.
Main Results:
- The initiation of insulitis was similar across genetic backgrounds.
- Significant differences in diabetes kinetics and penetrance were observed between the two backgrounds.
- These differences mapped to five distinct genomic intervals, some previously linked to autoimmune disease susceptibility.
Conclusions:
- The reductionist approach using the transgenic model simplified the identification of autoimmune diabetes susceptibility loci.
- The identified genomic intervals provide targets for further investigation into diabetes pathogenesis.
- This study highlights the importance of genetic background in modulating autoimmune disease progression.